Receptor-associated Mad homologues synergize as effectors of the TGF-beta response
- PMID: 8774881
- DOI: 10.1038/383168a0
Receptor-associated Mad homologues synergize as effectors of the TGF-beta response
Abstract
Transforming growth factor-beta TGF-beta is the prototype for a family of extracellular proteins that affect cell proliferation and tissue differentiation. TGF-beta-related factors, including BMP-2/4, Dpp and activin, act through two types of serine/threonine kinase receptors which can form a heteromeric complex. However, the mechanism of signal transduction by these receptors is largely unknown. In Drosophila, Mad is required for signalling by Dpp. We have isolated complementary DNAs for four human Mad homologues, one of which, hMAD-4, is identical to DPC-4, a candidate tumour suppressor. hMAD-3 and -4 synergized to induce strong ligand-independent TGF-beta-like responses. When truncated at their carboxy termini, hMAD-3 and -4 act as dominant-negative inhibitors of the normal TGF-beta response. The activity of hMAD-3 and -4 was regulated by the TGF-beta receptors, and hMAD-3 but not hMAD-4 was phosphorylated and associated with the ligand-bound receptor complex. These results define hMAD-3 and -4 as effectors of the TGF-beta response and demonstrate a function for DPCA-4/hMAD-4 as a tumour suppressor.
Similar articles
-
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.EMBO J. 1997 Sep 1;16(17):5353-62. doi: 10.1093/emboj/16.17.5353. EMBO J. 1997. PMID: 9311995 Free PMC article.
-
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.Cancer Res. 2004 Aug 1;64(15):5200-11. doi: 10.1158/0008-5472.CAN-04-0018. Cancer Res. 2004. PMID: 15289325
-
Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.J Cell Physiol. 1998 Jun;175(3):305-13. doi: 10.1002/(SICI)1097-4652(199806)175:3<305::AID-JCP8>3.0.CO;2-S. J Cell Physiol. 1998. PMID: 9572475
-
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.Cell Signal. 2013 Oct;25(10):2017-24. doi: 10.1016/j.cellsig.2013.06.001. Epub 2013 Jun 11. Cell Signal. 2013. PMID: 23770288 Review.
-
TGF-beta signal transduction.Annu Rev Biochem. 1998;67:753-91. doi: 10.1146/annurev.biochem.67.1.753. Annu Rev Biochem. 1998. PMID: 9759503 Review.
Cited by
-
Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines.BMC Cancer. 2016 Jul 8;16:431. doi: 10.1186/s12885-016-2468-x. BMC Cancer. 2016. PMID: 27391030 Free PMC article.
-
Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.Mol Cell Biol. 2005 Sep;25(18):8108-25. doi: 10.1128/MCB.25.18.8108-8125.2005. Mol Cell Biol. 2005. PMID: 16135802 Free PMC article.
-
Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.Cancer Cell. 2006 Jun;9(6):445-57. doi: 10.1016/j.ccr.2006.04.025. Cancer Cell. 2006. PMID: 16766264 Free PMC article.
-
Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.EMBO J. 2001 Aug 1;20(15):4132-42. doi: 10.1093/emboj/20.15.4132. EMBO J. 2001. PMID: 11483516 Free PMC article.
-
Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms.Mol Endocrinol. 2011 May;25(5):715-31. doi: 10.1210/me.2010-0236. Epub 2011 Mar 10. Mol Endocrinol. 2011. PMID: 21393444 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous